After sharing word that it would be prioritizing artificial intelligence to aid discovery work, Takeda Pharmaceuticals has inked a multiyear deal to access Iambic Therapeutics' broad suite of drug ...
Iambic, a clinical-stage life science and technology company developing novel medicines using its AI-driven discovery and development platform, today announced a multi-year technology and discovery ...
Multi-year partnership will utilize Iambic’s broad suite of AI drug discovery technologies and wet lab capabilities to advance collaboration programs initially in Takeda’s Oncology and ...
Takeda Pharmaceutical will apply Iambic Therapeutics’ artificial intelligence (AI)-based technologies and wet lab capabilities to design and develop small molecule drugs starting with two of Takeda’s ...
Three researchers wearing blue lab coats in a laboratory Iambic uses both physics- and AI-based machine learning models. Credit: Iambic Therapeutics Iambic Therapeutics, a San Diego–based start-up ...
As the 2026 Winter Olympic Games kick off with the opening ceremony, at least a dozen athletes will represent AIN. The three-letter acronym isn't an abbreviation of a country delegation — its athletes ...
"Bridgerton" Season 4 has a new romantic lead who holds a unique place in London society. Sophie Baek, played by Yerin Ha, is first introduced as the lady in silver, a woman who captivates our hero, ...
Owner lying in wait catches brazen car keyer red-handed US seizes Russian oil tanker in Atlantic China’s ‘artificial sun’ breaks fusion limit thought to be impossible Man shot by police after dramatic ...
President Donald Trump is set to deliver a live, prime-time address from the White House on Wednesday, but what is it for and what will he discuss? Trump, announcing his plans in a post on his social ...
Three amateur club champions emerged victorious in the Women’s Divisions at the 2025 PGA National Club Championship in Southern California. The Championship featured three Women’s Divisions: Open (any ...
Iambic, a clinical-stage life science and technology company that uses artificial intelligence to develop medicines has raised more than $100 million in an oversubscribed financing round. The Nov. 10 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results